Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.

ABSTRACT:

SUBMITTER: Moreau P 

PROVIDER: S-EPMC9989580 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature